Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BSNDP3 is a pseudogene derived from the BSND (barttin) gene, which encodes an accessory beta subunit for chloride channels. The functional BSND protein is essential for kidney salt reabsorption and hearing, operating as a chaperone and regulatory subunit for CLCNKA and CLCNKB channels. BSNDP3, however, does not encode a functional protein, nor does it participate in chloride transport or serve as a molecular drug target. Its primary significance is in genomic context; it may be referenced in gene mapping or transcriptome analysis but does not have direct biological function, clinical implications, or relevance to drug discovery. If your interest is in therapeutic targets related to barttin or chloride channels, focus on the functional BSND gene and protein, not the BSNDP3 pseudogene.
None applicable to this pseudogene; mechanisms of action are relevant to the functional BSND protein and associated chloride channels
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Barttin CLCNK-type accessory beta subunit pseudogene 3 (BSNDP3).